ITGAL

Chr 16

integrin subunit alpha L

The integrin alpha L chain combines with integrin beta 2 to form LFA-1, which mediates leukocyte adhesion, migration, and immune cell interactions through binding to intercellular adhesion molecules. Mutations cause leukocyte adhesion deficiency type 1, an autosomal recessive primary immunodeficiency characterized by recurrent severe bacterial infections, delayed wound healing, and absent pus formation due to impaired neutrophil migration. The gene is highly constrained against loss-of-function variants, reflecting its essential role in immune function.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 0.411 OMIM phenotype
Clinical SummaryITGAL
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.27) despite low pLI — interpret in context.
Some data sources returned errors (1)

ncbi: Error: NCBI fetch failed: 429 https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.41LOEUF
pLI 0.004
Z-score 5.29
OE 0.27 (0.190.41)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
2.18Z-score
OE missense 0.76 (0.710.82)
521 obs / 681.3 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.27 (0.190.41)
00.351.4
Missense OE0.76 (0.710.82)
00.61.4
Synonymous OE0.94
01.21.6
LoF obs/exp: 17 / 62.0Missense obs/exp: 521 / 681.3Syn Z: 0.79
DN
0.6646th %ile
GOF
0.6833th %ile
LOF
0.2776th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

ITGAL · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →